What is Oppenheimer's price target for CCAP?

Oppenheimer's latest stated price target for Crescent Capital BDC Inc. (CCAP) is $19, from its action on Aug 12, 2022.

What is Oppenheimer's rating on CCAP?

Oppenheimer rates CCAP Perform, a neutral rating, as of May 15, 2026.

When did Oppenheimer last change its view on CCAP?

On May 15, 2026, Oppenheimer downgrades to Perform from Outperform.

Oppenheimer CCAP price target and rating history

Crescent Capital BDC Inc. (CCAP) · Finance

Oppenheimer rates Crescent Capital BDC Inc. (CCAP) Perform with a $19 price target, as of its latest action on May 15, 2026. It has published 3 rating actions on CCAP since July 2021, including 1 upgrade and 1 downgrade.

Current rating: Perform
Price target: $19
Median target, all firms: Too few
Actions on CCAP: 3

Every Oppenheimer rating on CCAP

May 15, 2026
DowngradeOppenheimer downgrades to Perform from Outperform
Aug 12, 2022
UpgradeOppenheimer upgrades to Outperform from Perform, price target $20 to $19
Jul 16, 2021
InitiateOppenheimer starts coverage at Perform

How other firms rate CCAP

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
Keefe, Bruyette & Woods	Mkt Perform	$12	Aug 17, 2026
Oppenheimer	Perform		May 15, 2026
B. Riley Securities	Buy	$13.50	May 15, 2026

Questions about Oppenheimer and CCAP

What is Oppenheimer's price target for CCAP?: Oppenheimer's latest stated price target for Crescent Capital BDC Inc. (CCAP) is $19, from its action on Aug 12, 2022.
What is Oppenheimer's rating on CCAP?: Oppenheimer rates CCAP Perform, a neutral rating, as of May 15, 2026.
When did Oppenheimer last change its view on CCAP?: On May 15, 2026, Oppenheimer downgrades to Perform from Outperform.

More CCAP rating histories

Keefe, Bruyette & Woods3

All Oppenheimer ratings CCAP news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.